NFKB1 and B-cell chronic lymphocytic leukemia: This has potentially clinical implications as a correlation between the NF-κB subunit Rel-A (p65) DNA binding in CLL cells and lymphocyte doubling time was identified, and Rel-A DNA binding was positively correlated with in vitro resistance to fludarabine[48].